Creutzfeldt-Jakob disease
From DrKoop's partner site on chronic pain, ChronicPainConnection.com
Creutzfeldt-Jakob disease (CJD) is a form of brain damage that causes a rapid decrease of mental function and movement. It is believed to result from a protein called a prion. A prion folds abnormally. This seems to encourage other proteins to have bad shapes, which affects their ability to function. Alternative Names Transmissible Spongiform Encephalopathy; vCJD; CJD Causes, incidence, and risk factors There are several types of Creutzfeldt-Jakob disease (CJD). The disorder itself is rare, occurring in about 1 out of 1 million people. It usually first appears in midlife, beginning between ages 20 and 70, with average age at onset of symptoms in the late 50s. advertisement
The "classic" types of CJD are:
NOTE: Classic CJD is not related to "mad cow" disease. New variant Creutzfeldt-Jakob disease (vCJD) is an infectious form of CJD that is related to "mad cow disease" (bovine spongiform encephalitis ). The agent responsible for mad cow disease is believed to be the same agent responsible for vCJD in humans. This type of CJD was first described in 1996 in the United Kingdom. New variant Creutzfeldt-Jacob disease accounts for less than 1% of cases, and tends to affect younger people. New variant CJD can result when someone is exposed to contaminated products. Some cases of nvCJD have occurred in adolescents who have received growth hormone made from the pituitary glands of cadavers (dead bodies). Prions cannot be destroyed by ordinary disinfection techniques used to prevent transmission of viruses and bacteria. As a result, the hormone remains contaminated. Cadaver-derived growth hormone has been replaced by synthetically manufactured growth hormone, so this source of contagion is no longer a problem. Other vCJD cases have occurred when people were given corneal transplants from infected donors, and from contaminated electrodes that were used in brain surgery (before it was known how to properly disinfect instruments). | ||||||||||||||||||||
What's HOTGet our free newsletterPR Newswire |
|